Subtitle: Innovative Pea Peptide with Muscle Growth and Repair Functions Adds to Company’s Growing IP Portfolio

Recently, good news arrived from the China National Intellectual Property Administration (CNIPA): the patent application titled ”Novel Pea Peptide with Muscle Repair and Growth Function and Its Preparation Method and Application” filed by Hainan Huayan Collagen Technology Co., Ltd. (hereinafter referred to as “Hainan Huayan”) has passed examination and has been officially granted patent rights!

As a National High-Tech Enterprise, one of the first batch of High-Tech “Gazelle” Enterprises in Hainan Province, a National Intellectual Property Advantage Enterprise, and recipient of the First Prize of Hainan Provincial Technological Invention Award, Hainan Huayan has undertaken 17 scientific research projects at national, provincial, and municipal levels. The company holds over 120 various patent authorizations, has established more than 80 enterprise standards, developed over ten complete product systems, and published multiple high-level SCI academic papers in the peptide field.

Market Demand

Recent tax data released by the State Administration of Taxation for 2025 clearly indicates sustained robust growth in the sports and health industry consumer market. Invoice data reveals that health management, wellness, and healthcare services have become new consumption hotspots:

• Health consultation services: Sales revenue increased by 11.7% year-on-year
• Wellness and healthcare services: Sales revenue increased by 12.0% year-on-year
• Sports and health services: Sales revenue increased by 16.5% year-on-year

In 2025, the fitness wave sweeping across the nation has also brought underlying health concerns into focus—including protein deficiency, bone injuries, myocardial maintenance, and exercise-induced anemia. These concerns are quietly giving rise to a massive and potentially limitless sports nutrition market.

According to research data cited in a recent report by Central China Securities:

• The global sports nutrition market was valued at 188.132 billion yuan in 2025
• Projected to reach 306.474 billion yuan by 2032, with a compound annual growth rate (CAGR) of 7.22%

The Chinese market is growing even faster:

• China’s sports nutrition food market was valued at 9.71 billion yuan in 2024
• Expected to reach 20.93 billion yuan by 2030, representing an average annual growth rate of 11.56%

Compared with Europe, the United States, Japan, South Korea, and Germany, China’s sports nutrition food market is currently in a period of transitional opportunity. Consumption scenarios are expanding from professional fitness to include daily health maintenance for the general public, outdoor sports, and youth physical supplementation. As more consumers become attentive to sports nutrition, an increasing number of brands are entering this dynamic space.

Patent Overview

The functionalization and high-value application of plant proteins represent an important initiative in implementing the ”Greater Food Vision” and achieving the strategic goals of ”Healthy China 2030.” In recent years, pea peptides have been scientifically validated for multiple functional activities, including:

• Antioxidant properties
• Blood pressure regulation support
• Blood glucose management support
• Intestinal microbiota modulation

These properties position pea peptides for broad application prospects in functional foods, special medical purpose foods (FSMP), and other health products.

The pea peptide obtained through the preparation method described in this invention exhibits several distinctive characteristics:

• High purity
• Low molecular weight
• High bioactivity

Most notably, it demonstrates excellent performance in promoting muscle repair and growth, addressing a core need in the expanding sports nutrition market.

Scientific Innovation

Since its establishment in 2005, Hainan Huayan has深耕 the field of small-molecule bioactive peptides for 21 years, consistently building its core competitiveness through independent technological innovation. The company has assembled a comprehensively skilled production team and a professionally robust R&D technical staff, forming the backbone of its scientific innovation, product development, and production management capabilities. Hainan Huayan actively leverages the innovative research strengths of academic institutions, continuously evolving into a national high-tech enterprise integrating innovation, research, and production.

Currently, Hainan Huayan relies on nearly 3,000 square meters of the Hainan Provincial Biological Peptide Engineering Technology Research Center and pilot-scale R&D base, established in collaboration with over ten research institutions including the China-Australia (Hainan) Biotechnology Research Institute Co., Ltd., Ocean University of China, Third Institute of Oceanography of the Ministry of Natural Resources, and Hainan University. The company has established a Biological Peptide and Special Enzyme Joint Laboratory with Ocean University of China; received approval from the Provincial Department of Industry and Information Technology to build one of the first batch of provincial-level manufacturing innovation centers—the Hainan Provincial Bioactive Peptide and Enzyme Engineering Joint Innovation Center; obtained recognition from the Provincial Development and Reform Commission as a Hainan Provincial Enterprise Technology Center—the Hainan Huayan Collagen Technology Co., Ltd. Technology Center; and has been approved by the Provincial Talent Bureau to establish the Hainan Huayan Postdoctoral Research Workstation.

R&D Team Composition:

• 85% of R&D team members hold Master’s degrees or above
• 8 professors and doctoral researchers
• 6 provincial-level high-level talents

Hainan Huayan has undertaken 17 national, provincial, and municipal R&D projects in recent years, achieving 14 corresponding阶段性研究成果或 completed project outcomes to date.

Adhering to the principle of ”Rooted in Hainan, Serving the World,” Hainan Huayan will continue to pursue a development strategy centered on scientific innovation and product leadership. The company remains committed to translating research成果 into practical applications, generating high added value from scientific achievements, continuously enhancing its core competitiveness, and contributing to the high-end development of China’s domestic bioactive peptide industry.

About Hainan Huayan Collagen Technology Co., Ltd.

Founded in July 2005, Hainan Huayan is a comprehensive enterprise integrating product R&D, production, and sales. As a national high-tech enterprise, the company specializes in extracting high-value nutritional products from动植物 and microbial sources through advanced enzymatic hydrolysis technology. Its diverse product portfolio includes fish collagen peptides, collagen tripeptides, collagen cyclic dipeptides, sea cucumber peptides, oyster peptides, as well as plant-based peptides including corn peptide, rice peptide, pea peptide, and soybean peptide. These products are widely used in health supplements, cosmetic ingredients, and medical materials. With a global footprint, Hainan Huayan exports to more than 50 countries and regions, including Japan, South Korea, the United States, Thailand, Singapore, Indonesia, and Malaysia.